Dr. Mike Ryan, executive director of the World Health Organization’s (WHO) health emergencies program, stressed on Wednesday that the drug dexamethasone is just one of many breakthroughs needed to “effectively deal” with COVID-19. He added that it should only be used under “close clinical supervision” and that it has only been shown to be useful in the treatment of patients who are severely ill.
Health
Coronavirus: WHO stresses dexamethasone ‘purely’ for use under clinical supervision
More Videos
-
Canada becomes 1st country to have individual cigarette warning labels
-
Anti-sunscreen claims circulating online spark criticism
-
Fact or fad? Decoding ‘Oatzempic,’ Liquid chlorophyll, and sugar substitutes
-
Health Matters: Norovirus spreading in Ontario, Alberta
-
Cancer survivor emphasizes importance of mental health care during diagnosis
-
Feds to invest $1 million on palliative care resource hub at Roger Neilson Children’s Hospice
You are viewing an Accelerated Mobile Webpage.
View Original Article